Mtv-1 superantigen trafficks independently of major histocompatibility complex class II directly to the B-cell surface by the exocytic pathway

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 2577-2588

  Grigg, Michael E ^a,c   Mcmahon, Christopher W ^c   Morkowski, Stanislaw ^c   Rudensky, Alexander Y ^c   Pullen, Ann M ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; DODECYL SULFATE SODIUM; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; EXOCYTOSIS; IMMUNOSTIMULATION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0031925580     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.2577-2588.1998     Document Type: Article

References (79)

1. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
2. Amigorena, S., J. R. Drake, P. Webster, and I. Mellman. 1994. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369:113-120.
3. Arroyo, J., E. Winchester, B. S. McLellan, and B. T. Huber. 1997. Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain. J. Virol. 71:1237-1245.
4. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707-716.
5. Beutner, U., E. Kraus, D. Kitamura, K. Rajewskv, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457-1466.
6. Beutner, U., B. McLellan, E. Kraus, and B. T. Huber. 1996. Lack of MMTV superantigen presentation in MHC class II-deficient mice. Cell. Immun. 168: 141-147.
7. Bikoff, E. K., L. Huang, V. Episkopou, J. van Meerwijk, K. N. Germain, and E. J. Robertson. 1993. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699-1712.
8. Blum, J. S., and P. Cresswell. 1988. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA 85:3975-3979.
9. Brandt-Carlson, C., and J. S. Butel. 1991. Detection and characterization of a glycoprotein encoded by the mouse mammary tumor virus long terminal repeat gene. J. Virol. 65:6051-6060.
10. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33-39.
11. Buerstedde, J. M., L. R. Pease, M. P. Bell, A. E. Nilson, G. Buerstedde, D. Murphy, and D. J. McKean. 1988. Identification of an immunodominant region on the I-Aβ chain using site-directed mutagenesis and DNA-mediated gene transfer. J. Exp. Med. 167:473-487.
12. Castellino, F., and R. N. Germain. 1995. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2:73-88.
13. Chervonsky, A. V., J. Xu, A. K. Barlow, M. Khery, R. A. Flavell, and C. A. Janeway. 1995. Direct physical interaction involving CD40 ligand on T cells and CD40 on B cells is required to propogate MMTV. Immunity 3:139-146.
14. Choi, Y., P. Marrack, and J. Kappler. 1992. Structural analysis of a mouse mammary tumor virus superantigen. J. Exp. Med. 175:847-852.
15. Cotner, T., E. Mellins, A. H. Johnson, and D. Pious. 1991. Mutations affecting antigen processing impair class II-restricted allorecognition. J. Immunol. 146:414-417.
16. Davidson, H. W., P. A. Reid, A. Lanzavecchia, and C. Watts. 1991. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell 67:105-116.
17. Delcourt, M., J. Thibodeau, F. Denis, and R. P. Sekaly. 1997. Paracrine transfer of mouse mammary tumor virus superantigen. J. Exp. Med. 185: 471-480.
18. Denzin, L. K., N. F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect of T2 cells. Immunity 1:595-606.
19. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αγ dimers and facilitates peptide loading. Cell 82: 155-165.
20. Fung-Leung, W., C. Surh, M. Lijedahl, J. Pang, D. Leturcq, P. A. Peterson, S. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278-1281.
21. Germain, R. N., and H. Quill. 1986. Unexpected expression of a unique mixed-isotype class II MHC molecule by transfected L-cells. Nature 320: 72-75.
22. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134-139.
23. Glimcber, L., D. McKean, E. Choi, and J. Seidman. 1985. Complex regulation of class II gene expression: analysis with class II mutant cell lines. J. Immunol. 135:3542-3550.
24. Golovkina, T., A. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637-645.
25. Griffith, I. J., N. Nabavi, Z. Ghogawala, C. G. Chase, M. Rodriguez, D. J. McKean, and L. H. Glimcher. 1988. Structural mutation affecting intracellular transport and cell surface expression of murine class II molecules. J. Exp. Med. 167:541-555.
26. 25a. Grigg, M. E., and A. M. Pullen. Unpublished data.
27. Guagliardi, L. E., B. Koppelman, J. S. Blum, M. S. Marks, P. Cresswell, and F. M. Brodsky. 1990. Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 343: 133-139.
28. Hammerling, G., U. Hammerling, and H. Lemke. 1979. Isolation of twelve monoclonal antibodies against Ia and H-2 antigens, serological characterization and reactivity with B and T lymphocytes. Immunogenetics 8:433-445.
29. + T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:359-366.
30. Held, W., G. Waanders, A. Shakbov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529-540.
31. Held, W., G. Waanders, H. Acha-Orbea, and H. R. MacDonald. 1994. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function. J. Exp Med. 180:2347-2351.
32. Kappler, J. W., U. Staerz, J. White, and P. Marrack. 1988. Self-tolerance eliminates T cells specific for Mis-modified products of the major histocompatibility complex. Nature 332:35-40.
33. Karlsson, L., A. Peleraux, R. Lindstedt, M. Liljedahl, and P. A. Peterson. 1994. Reconstitution of an operational MHC class II compartment in non-antigen-presenting cells. Science 266:1569-1573.
34. Kim, J., R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266:1870-1874.
35. Klausner, R. 1989. Sorting and traffic in the central vacuolar system. Cell 57: 703-706.
36. Koch, N., S. Koch, and G. Hammerling. 1982. Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody. Nature 299:644-645.
37. Korman, A., P. Bourgarel, T. Meo, and G. Rieckhof. 1992. The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J. 11:1901-1905.
38. Kvist, S., K. Wiman, L. Claesson, P. A. Peterson, and B. Dobberstein. 1982. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell 29:61-69.
39. Lafon, M., M. Lafage, A. Martinex-Arends, R. Ramirez, F. Vuillier, D. Charron, V. Lotteau, and D. Scott-Algara. 1992. Evidence for a viral superantigen in humans. Nature 358:507-510.
40. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374-1378.
41. Li, Q., M. K. Spriggs, S. Kovats, S. M. Turk, M. R. Comeau, B. Nepom, and L. M. Hutt-Fletcher. 1997. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71:4657-4662.
42. Lippincott-Schwartz, J., L. C. Yuan, J. S. Bonifacino, and R. D. Klausner. 1989. Rapid redistribution of golgi proteins into the ER in cells treated with Brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56: 801-813.
43. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S. L. Schmid, V. Quaranta, and P. A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600-605.
44. Lund, F. E., T. D. Randall, D. L. Woodland, and R. B. Corley. 1993. MHC class II limits the functional expression of endogenous superantigens in B cells. J. Immunol. 150:78-86.
45. a-encoded antigens. Nature 332:40-45.
46. McMahon, C. W., L. Y. Bogatzki, and A. M. Pullen. 1997. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells. Virology 228:161-170.
47. McMahon, C. W., and A. M. Pullen. Unpublished data.
48. Mix, D., and G. M. Winslow. 1996. Proteolytic processing activates a viral superantigen. J. Exp. Med. 184:1549-1554.
49. Morkowski, S., G. Raposo, M. Kleijmeer, H. J. Geuze, and A. Y. Rudensky. 1997. Assembly of an abundant endogenous major histocompatibility complex class II/peptide complex in class II compartments. Eur. J. Immunol. 27: 609-617.
50. Neefjes, J., and H. L. Ploegh. 1992. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers in endosomes. EMBO J. 11:411-416.
51. Park, C., M. Jung, Y. Choi, and G. Winslow. 1995. Proteolytic processing is required for viral superantigen activity. J. Exp. Med. 181:1899-1904.
52. Peters, P. J., J. Neefjes, V. Oorschot, H. L. Ploegh, and H. J. Geuze. 1991. Segregation of MHC class II molecules from MHC class I molecules in the golgi complex for transport to lysosomal compartments. Nature 349:669-676.
53. Pullen, A. M., P. Marrack, and J. W. Kappler. 1988. The T cell repertoire is heavily influenced by tolerance to polymorphic self antigens. Nature 335: 796-801.
54. Pullen, A. M., and L. Y. Bogatzki. 1996. Receptors on T cells escaping superantigen-mediated deletion lack special β-chain junctional region structural characteristics. J. Immunol. 156:1865-1872.
55. Qui, Y., X. Xu, A. Wandinger-Ness, D. P. Dalke, and S. K. Pierce. 1994. Separation of subcellular compartments containing distinct functional forms of MHC class II. J. Cell Biol. 125:595-605.
56. Riberdy, J. M., and P. Cresswell. 1992. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J Immunol. 8:2586-2590.
57. Roche, P. A., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345-615-618.
58. Roche, P. A., C. L. Teletski, E. Stang, O. Bakke, and E. O. Long. 1993. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc. Natl. Acad. Sci. USA 90:8581-8585.
59. Romagnoli, P., C. Layet, J. Yewdell, O. Bakke, and R. N. Germain. 1993. Relationship between invariant chain and MHC class II transport into early and late endocytic compartments. J. Exp. Med. 177:583-596.
60. Rudensky, A. Y., M. Marie, S. Eastman, L. Shoemaker, P. C. DeRoos, and J. S. Blum. 1994. Intracellular assembly and transport of endogenous peptide-MHC class II complexes. Immunity 1:585-594.
61. Sanderson, F., M. J. Kleijmeer, A. Kelly, D. Verwoerd, A. Tulp, J. Neefjes, H. J. Geuze, and J. Trowsdale. 1994. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266:1566-1569.
62. Sette, A., S. Southwood, J. Miller, and E. Appella. 1995. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med 181: 677-683.
63. Sherman, M. A., D. A. Weber, and P. E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197-205.
64. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides for HLA-DR. Nature 375:802-806.
65. Smith, H. P., P. Le, D. L. Woodland, and M. A. Blackman. 1992. T cell receptor α-chain influences reactivity to Mls-1 in Vβ8.1 transgenic mice. J. Immunol. 149:887-896.
66. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-221.
67. Sutkowski, N., T. Palkama, C. Ciurli, R. P. Sekaly, D. A. Thorley-Lawson, and B. T. Huber. 1996. An Epstein-Barr virus-associated superantigen. J. Exp. Med. 184:971-980.
68. Thibodeau, J., I. Cloutier, P. M. Lavoie, N. Labrecque, W. Mourad, T. Jardetzky, and R. Sekaly. 1994. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science 266:1874-1878.
69. Tripp, R. A., A. M. Hamilton-Easton, R. D. Cardin, P. Nguyen, F. G. Behm, D. L. Woodland, P. C. Doherty, and M. A. Blackman. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J. Exp. Med. 185:1641-1650.
70. Tulp, A., D. Verwoerd, B. Dobberstein, H. Ploegh, and J. Pieters. 1994. Isolation and characterization of the intracellular MHC class II compartment. Nature 369:120-126.
71. a superantigen-specific T cell responses. J. Exp. Med. 175:1405-1408.
72. Viville, S., J. Neefjes, V. Lotteau, A. Dierich, M. Lemeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635-648.
73. West, M. A., J. Lucocq, and C. Watts. 1994. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 369:147-151.
74. White, J., A. M. Pullen, K. Choi, P. Marrack, and J. Kappler. 1993. Antigen recognition properties of mutant Vβ3+ T cell receptors are consistent with an immunoglobulin-like structure for the receptor. J. Exp. Med. 177:119-125.
75. Wiertz, E. J. H. J., S. Mukherjee, and H. L. Ploegh. 1997. Viruses use stealth technology to escape from the host immune system. Mol. Med. Today 3: 116-123.
76. Winslow, G., M. Scherer, J. Kappler, and P. Marrack. 1992. Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mls-1a). Cell 71:719-730.
77. Winslow, G., P. Marrack, and J. Kappler. 1994. Processing and major histocompatibility complex binding of the MTV7 superantigen. Immunity 1: 23-33.
78. Winslow, G., J. Kappler, and P. Marrack. 1997. Structural features of MMTV superantigens, p. 37-60. In D. Y. M. Leung, B. T. Huber, and P. M. Schlievert (ed.), Superantigens: molecular biology, immunology, and relevance to human disease. Marcel Dekker Inc., New York, N.Y.
79. Yazdanbaksh, K., C. Park, G. M. Winslow, and Y. Choi. 1993. Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor Vβ specificity. J. Exp. Med. 178: 737-741.